Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients

BACKGROUND: Ovarian cancer is a common gynaecological malignancy still remaining a challenge to treat. The objective of this study was to evaluate the impact of platinum dose reduction and chemotherapy delays on progression free survival and overall survival in patients with stage III ovarian cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Liutkauskiene, Sigita, Janciauskiene, Rasa, Jureniene, Kristina, Grizas, Saulius, Malonyte, Rasa, Juozaityte, Elona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359455/
https://www.ncbi.nlm.nih.gov/pubmed/25879527
http://dx.doi.org/10.1186/s12885-015-1104-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359455/
https://www.ncbi.nlm.nih.gov/pubmed/25879527
http://dx.doi.org/10.1186/s12885-015-1104-5

Ejemplares similares